Albert M Kim Selected Research

Albert M Kim Research Topics

3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2017
2	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2019
2	Body Weight (Weight, Body) 01/2021 - 12/2017
2	Inflammation (Inflammations) 01/2019 - 01/2010
2	Heart Failure 01/2017 - 01/2016
1	Obesity 01/2021
1	Atherosclerosis 01/2019
1	Myocardial Infarction 01/2019
1	Weight Loss (Weight Reduction) 12/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Injection Site Reaction 01/2017
1	Tachycardia (Tachyarrhythmias) 09/2009

2	Triglycerides (Triacylglycerol)IBA 11/2019 - 12/2017
2	LipidsIBA 12/2017 - 01/2017
1	Protons (Proton)IBA 01/2023
1	ketohexokinaseIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	DiglyceridesIBA 11/2019
1	AcyltransferasesIBA 11/2019
1	Diacylglycerol O-AcyltransferaseIBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	2- (6- (5- chloro- 2- methoxyphenyl)- 4- oxo- 2- thioxo- 3,4- dihydropyrimidin- 1(2H)- yl)acetamideIBA 01/2019
1	HDL CholesterolIBA 12/2017
1	PF-05231023IBA 12/2017
1	fibroblast growth factor 21IBA 12/2017
1	Atorvastatin (Lipitor)FDA Link 12/2017
1	AdiponectinIBA 12/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	bococizumabIBA 01/2017
1	CytokinesIBA 01/2010

3	Therapeutics 01/2017 - 01/2016
1	Catheters 09/2009